S100 proteins in cartilage: Role in arthritis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 4, 2012, Pages 600-606

  Yammani, Raghunatha R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Cartilage; Chondrocyte; Osteoarthritis (OA); S100 protein

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; CALGRANULIN A; CALGRANULIN B; CALVASCULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; LIPOCORTIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN S 100; PROTEIN S100A11; PROTEIN S100A2; PROTEIN S100B; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; UNCLASSIFIED DRUG;

ARTHRITIS; BONE; BONE MARROW CELL; CALCIFICATION; CALCIUM HOMEOSTASIS; CARTILAGE; CARTILAGE CELL; CELL CYCLE REGULATION; CELL FUNCTION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CYTOPLASM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTRACELLULAR MEMBRANE; JOINT; MOLECULAR BIOLOGY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS; CARTILAGE; HUMANS; S100 PROTEINS;

VERTEBRATA;

EID: 84856411199     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.01.006     Document Type: Review

References (115)

1. Moore B.W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 1965, 19:739-744.
2. Donato R. Perspectives in S-100 protein biology. Review article. Cell Calcium 1991, 12:713-726.
3. Krebs J., Quadroni M., Van Eldik L.J. Dance of the dimers. Nat. Struct. Biol. 1995, 2:711-714.
4. Fritz G., Botelho H.M., Morozova-Roche L.A., Gomes C.M. Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. FEBS J. 2010, 277:4578-4590.
5. Schafer B.W., Wicki R., Engelkamp D., Mattei M.G., Heizmann C.W. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995, 25:638-643.
6. Schafer B.W., Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 1996, 21:134-140.
7. Wicki R., Marenholz I., Mischke D., Schafer B.W., Heizmann C.W. Characterization of the human S100A12 (calgranulin C, p6, CAAF1, CGRP) gene, a new member of the S100 gene cluster on chromosome 1q21. Cell Calcium 1996, 20:459-464.
8. Shang X., Cheng H., Zhou R. Chromosomal mapping, differential origin and evolution of the S100 gene family. Genet. Sel. Evol. 2008, 40:449-464.
9. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001, 33:637-668.
10. Mandinova A., Atar D., Schafer B.W., Spiess M., Aebi U., Heizmann C.W. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci. 1998, 111(Pt 14):2043-2054.
11. Moroz O.V., Blagova E.V., Wilkinson A.J., Wilson K.S., Bronstein I.B. The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisation. J. Mol. Biol. 2009, 391:536-551.
12. Koch M., Bhattacharya S., Kehl T., Gimona M., Vasak M., Chazin W., Heizmann C.W., Kroneck P.M., Fritz G. Implications on zinc binding to S100A2. Biochim. Biophys. Acta 2007, 1773:457-470.
13. Ostendorp T., Leclerc E., Galichet A., Koch M., Demling N., Weigle B., Heizmann C.W., Kroneck P.M., Fritz G. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 2007, 26:3868-3878.
14. Sastry M., Ketchem R.R., Crescenzi O., Weber C., Lubienski M.J., Hidaka H., Chazin W.J. The three-dimensional structure of Ca(2+)-bound calcyclin: implications for Ca(2+)-signal transduction by S100 proteins. Structure 1998, 6:223-231.
15. Ishikawa K., Nakagawa A., Tanaka I., Suzuki M., Nishihira J. The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9A resolution. Acta Crystallogr. 2000, 56:559-566.
16. Moroz O.V., Antson A.A., Dodson G.G., Wilson K.S., Skibshoj I., Lukanidin E.M., Bronstein I.B. Crystallization and preliminary X-ray diffraction analysis of human calcium-binding protein S100A12. Acta Crystallogr. 2000, 56:189-191.
17. Heizmann C.W., Ackermann G.E., Galichet A. Pathologies involving the S100 proteins and RAGE. Subcell. Biochem. 2007, 45:93-138.
18. van der Eerden B.C., Hoenderop J.G., de Vries T.J., Schoenmaker T., Buurman C.J., Uitterlinden A.G., Pols H.A., Bindels R.J., van Leeuwen J.P. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17507-17512.
19. Cecil D.L., Terkeltaub R. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. J. Immunol. 2008, 180:8378-8385.
20. Streicher W.W., Lopez M.M., Makhatadze G.I. Modulation of quaternary structure of S100 proteins by calcium ions. Biophys. Chem. 2010, 151:181-186.
21. Pedrocchi M., Schafer B.W., Durussel I., Cox J.A., Heizmann C.W. Purification and characterization of the recombinant human calcium-binding S100 proteins CAPL and CACY. Biochemistry 1994, 33:6732-6738.
22. Heizmann C.W., Cox J.A. New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals 1998, 11:383-397.
23. Allen B.G., Durussel I., Walsh M.P., Cox J.A. Characterization of the Ca2+-binding properties of calgizzarin (S100C) isolated from chicken gizzard smooth muscle. Biochem. Cell Biol. 1996, 74:687-694.
24. Baudier J., Glasser N., Gerard D. Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein. J. Biol. Chem. 1986, 261:8192-8203.
25. Franz C., Durussel I., Cox J.A., Schafer B.W., Heizmann C.W. Binding of Ca2+ and Zn2+ to human nuclear S100A2 and mutant proteins. J. Biol. Chem. 1998, 273:18826-18834.
26. Filipek A., Heizmann C.W., Kuznicki J. Calcyclin is a calcium and zinc binding protein. FEBS Lett. 1990, 264:263-266.
27. Nishikawa T., Lee I.S., Shiraishi N., Ishikawa T., Ohta Y., Nishikimi M. Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage. J. Biol. Chem. 1997, 272:23037-23041.
28. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 2003, 60:540-551.
29. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr. Mol. Med. 2007, 7:711-724.
30. Yammani R.R., Carlson C.S., Bresnick A.R., Loeser R.F. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum. 2006, 54:2901-2911.
31. Loser K., Vogl T., Voskort M., Lueken A., Kupas V., Nacken W., Klenner L., Kuhn A., Foell D., Sorokin L., Luger T.A., Roth J., Beissert S. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat. Med. 2010, 16:713-717.
32. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., Nacken W., Foell D., van der Poll T., Sorg C., Roth J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13:1042-1049.
33. Bhattacharya S., Large E., Heizmann C.W., Hemmings B., Chazin W.J. Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase. Biochemistry 2003, 42:14416-14426.
34. Endo H., Takenaga K., Kanno T., Satoh H., Mori S. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. J. Biol. Chem. 2002, 277:26396-26402.
35. Treves S., Scutari E., Robert M., Groh S., Ottolia M., Prestipino G., Ronjat M., Zorzato F. Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle. Biochemistry 1997, 36:11496-11503.
36. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta 1999, 1450:191-231.
37. Sorci G., Agneletti A.L., Bianchi R., Donato R. Association of S100B with intermediate filaments and microtubules in glial cells. Biochim. Biophys. Acta 1998, 1448:277-289.
38. Bresnick A.R. Molecular mechanisms of nonmuscle myosin-II regulation. Curr. Opin. Cell Biol. 1999, 11:26-33.
39. Rustandi R.R., Baldisseri D.M., Weber D.J. Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat. Struct. Biol. 2000, 7:570-574.
40. Chen H., Fernig D.G., Rudland P.S., Sparks A., Wilkinson M.C., Barraclough R. Binding to intracellular targets of the metastasis-inducing protein, S100A4. Biochem. Biophys. Res. Commun. 2001, 286:1212-1217.
41. Grigorian M., Andresen S., Tulchinsky E., Kriajevska M., Carlberg C., Kruse C., Cohn M., Ambartsumian N., Christensen A., Selivanova G., Lukanidin E. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J. Biol. Chem. 2001, 276:22699-22708.
42. Mueller A., Schafer B.W., Ferrari S., Weibel M., Makek M., Hochli M., Heizmann C.W. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J. Biol. Chem. 2005, 280:29186-29193.
43. Reeves R.H., Yao J., Crowley M.R., Buck S., Zhang X., Yarowsky P., Gearhart J.D., Hilt D.C. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:5359-5363.
44. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 1996, 271:2543-2547.
45. Hu J., Ferreira A., Van Eldik L.J. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 1997, 69:2294-2301.
46. Perera C., McNeil H.P., Geczy C.L. S100 calgranulins in inflammatory arthritis. Immunol. Cell Biol. 2010, 88:41-49.
47. Hu S.P., Harrison C., Xu K., Cornish C.J., Geczy C.L. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood 1996, 87:3919-3928.
48. Salama I., Malone P.S., Mihaimeed F., Jones J.L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 2008, 34:357-364.
49. Marshak D.R., Pena L.A. Potential role of S100 beta in Alzheimer's disease: an hypothesis involving mitotic protein kinases. Prog. Clin. Biol. Res. 1992, 379:289-307.
50. Griffin W.S. Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 2006, 83:470S-474S.
51. Foell D., Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 2004, 50:3762-3771.
52. Stefansson K., Wollmann R.L., Moore B.W., Arnason B.G. S-100 protein in human chondrocytes. Nature 1982, 295:63-64.
53. Nakamura Y., Becker L.E., Marks A. S-100 protein in tumors of cartilage and bone. An immunohistochemical study. Cancer 1983, 52:1820-1824.
54. Okajima K., Honda I., Kitagawa T. Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage. Cancer 1988, 61:792-799.
55. Ushigome S., Takakuwa T., Shinagawa T., Takagi M., Kishimoto H., Mori N. Ultrastructure of cartilaginous tumors and S-100 protein in the tumors. With reference to the histogenesis of chondroblastoma, chondromyxoid fibroma and mesenchymal chondrosarcoma. Acta Pathol. Jpn. 1984, 34:1285-1300.
56. Hasegawa T., Seki K., Yang P., Hirose T., Hizawa K., Wada T., Wakabayashi J. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum. Pathol. 1995, 26:838-845.
57. Li C.L., Martinez V., He B., Lombet A., Perbal B. A role for CCN3 (NOV) in calcium signalling. Mol. Pathol. 2002, 55:250-261.
58. Chano T., Ishizawa M., Matsumoto K., Morimoto S., Hukuda S., Okabe H. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein. Eur. J. Histochem. 1995, 39:21-30.
59. Weiss A.P., Dorfman H.D. S-100 protein in human cartilage lesions. J. Bone Joint Surg. Am. 1986, 68:521-526.
60. Mohr W., Kuhn C., Pelster B., Wessinghage D. S-100 protein in normal, osteoarthrotic, and arthritic cartilage. Rheumatol. Int. 1985, 5:273-277.
61. Wolff D.A., Stevenson S., Goldberg V.M. S-100 protein immunostaining identifies cells expressing a chondrocytic phenotype during articular cartilage repair. J. Orthop. Res. 1992, 10:49-57.
62. Leonardi R., Villari L., Bernasconi G., Piacentini C., Baciliero U., Travali S. Cellular S-100 protein immunostaining in human dysfunctional temporomandibular joint discs. Arch. Oral Biol. 2000, 45:411-418.
63. Itoi M. An experimental study on the relationship between S-100 protein synthesis and differentiation of chondrocytes. J. Kyoto Prefectural Univ. Med. 1988, 97:1395-1406.
64. Sugimoto S., Kusuzaki K., Takeshita H., Kuzuhara A., Tsuji Y., Yamashita F., Hirasawa Y., Ashihara T. The distribution of S-100 protein positive chondrocytes in the human articular cartilages under aging or diseased conditions. Nippon Seikeigeka Gakkai Zasshi 1991, 65:902-908.
65. Cecil D.L., Johnson K., Rediske J., Lotz M., Schmidt A.M., Terkeltaub R. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J. Immunol. 2005, 175:8296-8302.
66. Loeser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., Im H.J., Bursch L.S., Yan S.D. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum. 2005, 52:2376-2385.
67. Balmain N., Moutahir F., Heizmann C.W., Lieberherr M. Immunolocalization of S100A2 calcium-binding protein in cartilage and bone cells. Cell. Mol. Biol. (Noisy-le-Grand) 2003, 49:485-486.
68. Hopwood B., Tsykin A., Findlay D.M., Fazzalari N.L. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res. Ther. 2007, 9:R100.
69. Yammani R.R., Long D., Loeser R.F. Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes. Arthritis Rheum. 2009, 60:792-800.
70. Miranda K.J., Loeser R.F., Yammani R.R. Sumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13. J. Biol. Chem. 2010, 285:31517-31524.
71. Zreiqat H., Howlett C.R., Gronthos S., Hume D., Geczy C.L. S100A8/S100A9 and their association with cartilage and bone. J. Mol. Histol. 2007, 38:381-391.
72. van Lent P.L., Grevers L.C., Blom A.B., Arntz O.J., van de Loo F.A., van der Kraan P., Abdollahi-Roodsaz S., Srikrishna G., Freeze H., Sloetjes A., Nacken W., Vogl T., Roth J., van den Berg W.B. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum. 2008, 58:3776-3787.
73. Baillet A., Trocme C., Berthier S., Arlotto M., Grange L., Chenau J., Quetant S., Seve M., Berger F., Juvin R., Morel F., Gaudin P. Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford) 2010, 49:671-682.
74. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. 2010, 6:625-635.
75. Youssef P., Roth J., Frosch M., Costello P., Fitzgerald O., Sorg C., Bresnihan B. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J. Rheumatol. 1999, 26:2523-2528.
76. van Lent P.L., Grevers L.C., Schelbergen R., Blom A., Geurts J., Sloetjes A., Vogl T., Roth J., van den Berg W.B. S100A8 causes a shift toward expression of activatory Fcgamma receptors on macrophages via toll-like receptor 4 and regulates Fcgamma receptor expression in synovium during chronic experimental arthritis. Arthritis Rheum. 2010, 62:3353-3364.
77. Zreiqat H., Belluoccio D., Smith M.M., Wilson R., Rowley L.A., Jones K., Ramaswamy Y., Vogl T., Roth J., Bateman J.F., Little C.B. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res. Ther. 2010, 12:R16.
78. van Lent P.L., Grevers L., Blom A.B., Sloetjes A., Mort J.S., Vogl T., Nacken W., van den Berg W.B., Roth J. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann. Rheum. Dis. 2008, 67:1750-1758.
79. Pan J., Rintala-Dempsey A.C., Li Y., Shaw G.S., Konermann L. Folding kinetics of the S100A11 protein dimer studied by time-resolved electrospray mass spectrometry and pulsed hydrogen-deuterium exchange. Biochemistry 2006, 45:3005-3013.
80. Rety S., Osterloh D., Arie J.P., Tabaries S., Seeman J., Russo-Marie F., Gerke V., Lewit-Bentley A. Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure 2000, 8:175-184.
81. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267:14998-15004.
82. Ding Q., Keller J.N. Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim. Biophys. Acta 2005, 1746:18-27.
83. Ding Q., Keller J.N. Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain. Neurosci. Lett. 2005, 373:67-72.
84. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
85. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 2000, 1498:99-111.
86. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
87. Basta G., Lazzerini G., Del Turco S., Ratto G.M., Schmidt A.M., De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1401-1407.
88. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 2000, 275:40096-40105.
89. Leclerc E., Fritz G., Weibel M., Heizmann C.W., Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 2007, 282:31317-31331.
90. Bianchi R., Adami C., Giambanco I., Donato R. S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 2007, 81:108-118.
91. Bianchi R., Giambanco I., Donato R. S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol. Aging 2010, 31:665-677.
92. Shaw S.S., Schmidt A.M., Banes A.K., Wang X., Stern D.M., Marrero M.B. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 2003, 52:2381-2388.
93. Reddy M.A., Li S.L., Sahar S., Kim Y.S., Xu Z.G., Lanting L., Natarajan R. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J. Biol. Chem. 2006, 281:13685-13693.
94. Cecil D.L., Appleton C.T., Polewski M.D., Mort J.S., Schmidt A.M., Bendele A., Beier F., Terkeltaub R. The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli. J. Immunol. 2009, 182:5024-5031.
95. Lu C., He J.C., Cai W., Liu H., Zhu L., Vlassara H. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11767-11772.
96. Ohgami N., Nagai R., Ikemoto M., Arai H., Kuniyasu A., Horiuchi S., Nakayama H. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J. Biol. Chem. 2001, 276:3195-3202.
97. Ohgami N., Nagai R., Ikemoto M., Arai H., Miyazaki A., Hakamata H., Horiuchi S., Nakayama H. CD36, serves as a receptor for advanced glycation endproducts. J. Diabetes Complications 2002, 16:56-59.
98. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 1993, 268:11811-11816.
99. Abumrad N.A., El-Maghrabi M.R., Amri E.Z., Lopez E., Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 1993, 268:17665-17668.
100. Dawson D.W., Pearce S.F., Zhong R., Silverstein R.L., Frazier W.A., Bouck N.P. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 1997, 138:707-717.
101. Asch A.S., Silbiger S., Heimer E., Nachman R.L. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 1992, 182:1208-1217.
102. Huang M.M., Bolen J.B., Barnwell J.W., Shattil S.J., Brugge J.S. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7844-7848.
103. Chen K., Febbraio M., Li W., Silverstein R.L. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ. Res. 2008, 102:1512-1519.
104. Bull H.A., Brickell P.M., Dowd P.M. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett. 1994, 351:41-44.
105. Moore K.J., El Khoury J., Medeiros L.A., Terada K., Geula C., Luster A.D., Freeman M.W. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 2002, 277:47373-47379.
106. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2009, 2:re3.
107. Silverstein R.L., Febbraio M. CD36 and atherosclerosis. Curr. Opin. Lipidol. 2000, 11:483-491.
108. Silverstein R.L. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve. Clin. J. Med. 2009, 76(Suppl 2):S27-S30.
109. Park L., Wang G., Zhou P., Zhou J., Pitstick R., Previti M.L., Younkin L., Younkin S.G., Van Nostrand W.E., Cho S., Anrather J., Carlson G.A., Iadecola C. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5063-5068.
110. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A., El Khoury J., Golenbock D.T., Moore K.J. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
111. Kiryushko D., Novitskaya V., Soroka V., Klingelhofer J., Lukanidin E., Berezin V., Bock E. Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol. Cell. Biol. 2006, 26:3625-3638.
112. Foell D., Wittkowski H., Vogl T., Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 2007, 81:28-37.
113. Sorci G., Riuzzi F., Agneletti A.L., Marchetti C., Donato R. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 2003, 23:4870-4881.
114. Riuzzi F., Sorci G., Donato R. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK. J. Cell. Physiol. 2006, 207:461-470.
115. Kerkhoff C., Sorg C., Tandon N.N., Nacken W. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 2001, 40:241-248.